Christopher Chapman
2022
In 2022, Christopher Chapman earned a total compensation of $261.8K as President, Chief Medical Officer at Akers Biosciences, a 95% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Salary | $161,827 |
| Total | $261,827 |
Chapman received $161.8K in salary, accounting for 62% of the total pay in 2022.
Chapman also received $100K in bonus.
Rankings
In 2022, Christopher Chapman's compensation ranked 5,203rd out of 5,760 executives tracked by ExecPay. In other words, Chapman earned more than 9.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,203 out of 5,760 | 10th |
Division Manufacturing | 2,859 out of 3,136 | 9th |
Major group Chemicals And Allied Products | 1,328 out of 1,422 | 7th |
Industry group Drugs | 1,248 out of 1,323 | 6th |
Industry In Vitro and In Vivo Diagnostic Substances | 25 out of 29 | 14th |
Source: SEC filing on June 30, 2023.
Chapman's colleagues
We found three more compensation records of executives who worked with Christopher Chapman at Akers Biosciences in 2022.
News
Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
November 1, 2024
Akers Biosciences CSO Adam Kaplin's 2022 pay falls 93% to $354K
June 30, 2023
Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
October 26, 2022
Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
November 22, 2021